Mersana Therapeutics Inc (MRSN)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current MRSN market cap is 53.02M. The company's latest EPS is USD -0.5552 and P/E is -0.77.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 10.7M | 9.25M | 2.29M | 12.6M | 16.36M |
| Operating Income | -21.39M | -21M | -25.46M | -12.07M | -14.81M |
| Net Income | -19.51M | -19.31M | -24.27M | -11.5M | -14.12M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 828k | 43k | 26.58M | 36.86M | 40.5M |
| Operating Income | -88.11M | -168.86M | -203.77M | -179.64M | -73.34M |
| Net Income | -88.05M | -170.06M | -204.21M | -171.64M | -69.19M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 226.06M | 198.37M | 179.13M | 169.53M | 144.66M |
| Total Liabilities | 189.16M | 170.39M | 170.7M | 168.48M | 154.17M |
| Total Equity | 36.9M | 27.99M | 8.43M | 1.05M | -9.51M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 273.4M | 206.11M | 334.34M | 226.06M | 144.66M |
| Total Liabilities | 45.31M | 84.37M | 242.28M | 189.16M | 154.17M |
| Total Equity | 228.09M | 121.74M | 92.06M | 36.9M | -9.51M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -168.88M | -32.66M | -63.11M | -63.09M | -82.34M |
| Investing | 119.88M | -72.55M | -67.03M | -38.56M | 11.44M |
| Financing | 94.68M | 5.83M | 6.24M | 5.96M | 4.09M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -74.7M | -139.99M | -49.36M | -168.88M | -82.34M |
| Investing | 37.03M | -648k | -152.72M | 119.88M | 11.44M |
| Financing | 230.41M | 63.65M | 153.02M | 94.68M | 4.09M |
| Market Cap | 53.02M |
| Price to Earnings Ratio | -0.77 |
| Price to Sales Ratio | 1.32 |
| Price to Cash Ratio | 0.5 |
| Price to Book Ratio | -5.64 |
| Dividend Yield | - |
| Shares Outstanding | 124.63M |
| Average Volume (1 week) | 2.94M |
| Average Volume (1 Month) | 3.3M |
| 52 Week Change | -90.97% |
| 52 Week High | 4.805 |
| 52 Week Low | 0.4045 |
| Spread (Intraday) | 0.02 (5.11%) |
| Company Name | Mersana Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.mersana.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
